MGMT Gene Promoter Methylation as a Potent Prognostic Factor in Glioblastoma Treated With Temozolomide-Based Chemoradiotherapy: A Single-Institution Study

Purpose Recently, cells deficient in O6 -methylguanine–DNA methyltransferase (MGMT) were found to show increased sensitivity to temozolomide (TMZ). We evaluated whether hypermethylation of MGMT was associated with survival in patients with glioblastoma multiforme (GBM). Methods and Materials We retr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of radiation oncology, biology, physics biology, physics, 2012-11, Vol.84 (3), p.661-667
Hauptverfasser: Kim, Young Suk, M.D, Kim, Se Hoon, M.D., Ph.D, Cho, Jaeho, M.D., Ph.D, Kim, Jun Won, M.D, Chang, Jong Hee, M.D., Ph.D, Kim, Dong Suk, M.D., Ph.D, Lee, Kyu Sung, M.D., Ph.D, Suh, Chang-Ok, M.D., Ph.D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!